Professor Shabir Madhi: AstraZeneca vaccine trials and Covid-19 death rate, lockdown.

Loading player...
In this interesting interview, Vaccinology Professor Shabir Madhi talks with BizNews Editor Jackie Cameron about a myriad of fascinating topics. The Professor shares his thoughts on the recent halt in the AstraZeneca Covid-19 vaccine trials and what that means for other vaccine trials, South Africa's relatively low Covid-19 death rate and gives his thoughts on the lockdown South Africa saw itself going into in late March of this year. Learn more about your ad choices. Visit megaphone.fm/adchoices
11 Sep 2020 8AM English South Africa Investing · Business News

Other recent episodes

The BizNews Edge: African Bank's Billion-Rand Acquisition Trap

African Bank swung to a loss of nearly a billion rand after a four-year spree of buying and bolting together three banks to build a full-service lender, and the bad debt charge is still climbing. The contrast is brutal: a focused platinum-and-chrome miner, Tharisa, is printing cash with profit up…
25 Jun 7AM 9 min

The BizNews Edge: Nedbank, Grindrod and the coal stock no one was watching

Nedbank confirmed its guidance this morning, and its East Africa deal is weeks from closing - a transformation most investors are still underpricing. Grindrod's Port of Maputo posted extraordinary volumes, but the share may already be priced for perfection. A small coal miner no one follows just disclosed an 1,800%…
24 Jun 8AM 26 min